SCHEMBL8404048

SCHEMBL8404048

CC(C)(C)c1cc(CC2(O)CC2)ccc1N

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 1/20 0.35
ALDH1A1 P00352 4/20 0.34
GAA P10253 2/20 0.34
LMNA P02545 2/20 0.34
TSHR P16473 2/20 0.34
HSPA5 P11021 1/20 0.33
FPR2 P25090 2/20 0.32
PROKR1 Q8TCW9 2/20 0.32
KDM4E B2RXH2 3/20 0.31
MAPT P10636 2/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
POLB P06746 1/20 0.31
RAB9A P51151 1/20 0.31
TDP1 Q9NUW8 1/20 0.30
GMNN O75496 1/20 0.30
GABBR2 O75899 1/20 0.30
TP53 P04637 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10286692 0.75 ALDH1A1 (0.38) OPRL1ALDH1A1GAATSHRFPR2
SCHEMBL117131 0.75 ALDH1A1 (0.48) ALDH1A1GAALMNATSHRHSPA5
SCHEMBL2153435 0.75 SKP2 (0.41) ALDH1A1GAALMNATSHRHSPA5
SCHEMBL21544165 0.73 ALDH1A1 (0.59) ALDH1A1GAALMNATSHRKDM4E
SCHEMBL2754720 0.70 ALDH1A1 (0.33) ALDH1A1GAAKDM4E
SCHEMBL11623056 0.67 HRH3 (0.46) ALDH1A1GAALMNATSHRKDM4E
SCHEMBL2155153 0.66 POLB (0.41) ALDH1A1GAATSHRKDM4EMAPT
Hydrochloric Acid SCHEMBL11620713 0.66 HRH3 (0.44) ALDH1A1GAALMNATSHRKDM4E
SCHEMBL5383436 0.65 ALDH1A1 (0.61) ALDH1A1GAALMNATSHRKDM4E
SCHEMBL18911954 0.65 GRIN2B (0.51) OPRL1MAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8198299-B2 Cycloalkylidene and heterocycloalkylidene inhibitor compounds GILEAD SCIENCES, INC. (US) 2012-06-12 US disclosed
US-8134000-B2 Imidazolyl pyrimidine inhibitor compounds GILEAD SCIENCES, INC. (US) 2012-03-13 US disclosed
US-20120045412-A1 CYCLOALKYLIDENE AND HETEROCYCLOALKYLIDENE INHIBITOR COMPOUNDS GILEAD SCIENCES, INC. (US) 2012-02-23 US disclosed
US-20100009990-A1 IMIDAZOLYL PYRIMIDINE INHIBITOR COMPOUNDS GILEAD SCIENCES, INC. 2010-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009990-A1 IMIDAZOLYL PYRIMIDINE INHIBITOR COMPOUNDS HDAC1, CDK9, CDK2 OPRL1 4858/4885ALDH1A1 1714/4885GAA 502/4885
US-20120045412-A1 CYCLOALKYLIDENE AND HETEROCYCLOALKYLIDENE INHIBITOR COMPOUNDS HDAC1, HDAC11, HDAC2 OPRL1 4451/4885ALDH1A1 957/4885GAA 79/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.